Selected article for: "detection method and international license"
Author: Wanbing Liu; Lei Liu; Guomei Kou; Yaqiong Zheng; Yinjuan Ding; Wenxu Ni; Qiongshu Wang; Li Tan; Wanlei Wu; Shi Tang; Zhou Xiong; Shangen Zheng
Title: Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2
  • Document date: 2020_3_20
    • ID: lm9pay2b_2
    Snippet: (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03. 16 Therefore, with the current tests it is difficult to achieve a meaningful assessment of 85 the proportion of symptomatic patients that are infected, and a rapid and accurate 86 detection method of COVID-19 is urgently needed. Serological assays are accurate 87 and efficient methods for the screening for many pathogens, as specific IgM and Ig.....
    Document: (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03. 16 Therefore, with the current tests it is difficult to achieve a meaningful assessment of 85 the proportion of symptomatic patients that are infected, and a rapid and accurate 86 detection method of COVID-19 is urgently needed. Serological assays are accurate 87 and efficient methods for the screening for many pathogens, as specific IgM and IgG 88 antibodies can be detected with ELISA, which has relatively high throughput capacity 89 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and detection method: 1
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and pathogen screening: 1
    • cc NC ND International license and symptomatic patient: 1
    • current test and International license: 1, 2
    • current test and serological assay: 1, 2
    • current test and throughput capacity: 1
    • detection method and International license: 1, 2, 3, 4
    • detection method and pathogen screening: 1, 2
    • detection method and serological assay: 1, 2, 3, 4
    • detection method and symptomatic patient: 1
    • detection method and urgently need: 1
    • International license and pathogen screening: 1
    • International license and symptomatic patient: 1, 2
    • serological assay and throughput capacity: 1, 2